Concepedia

E. Megan Flynn

EM

Statistics

Publications

12

Citations

1.5K

H-Index

12

Active since

2003

Affiliations

Constellation Pharmaceuticals (United States)(Current)

WuXi AppTec (China)

Cochrane

University of Kentucky

E. Megan Flynn is an author at Constellation Pharmaceuticals (United States) specializing in molecular biology, life sciences, and pharmacology.

Publications per year

2003–2018

12

Publications

12

Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation

Ryan Raisner, Samir Kharbanda, Lingyan Jin et al. · Cell Reports · 2018 · 415 citations · Full text

, , +17

An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells

Maia Vinogradova, Victor Gehling, Amy Gustafson et al. · Nature Chemical Biology · 2016 · 357 citations · Full text

, , +14

A Subset of Human Bromodomains Recognizes Butyryllysine and Crotonyllysine Histone Peptide Modifications

E. Megan Flynn, Oscar W. Huang, Florence Poy et al. · Structure · 2015 · 215 citations · Full text

, , +11

Mechanism of multiple lysine methylation by the SET domain enzyme Rubisco LSMT

Raymond C. Trievel, E. Megan Flynn, Robert L. Houtz et al. · Nature Structural & Molecular Biology · 2003 · 131 citations

, , +13

Diving into the Water: Inducible Binding Conformations for BRD4, TAF1(2), BRD9, and CECR2 Bromodomains

Terry D. Crawford, Vickie Tsui, E. Megan Flynn et al. · Journal of Medicinal Chemistry · 2016 · 118 citations · Full text

, , +12

1–5 of 12